Catalyst overview
Research summary
This catalyst tracks a Phase 1 data readout for KYV-101 in Lupus nephritis. The expected timing is based on the latest available company guidance and may change.
KYSA-1/KYSA-2 trials. Ongoing trial. 7/29/25- KOL event on Aug 28, 2025. 03/26/26:- Phase 1 lupus nephritis data from KYSA-1/2 expected in 2026. 05/12/26:- PR No update. 08/11/26:- PR No update.
Verification
Confirm timing and program details against the company announcement or filing.